A prime-boost immunisation regimen using recombinant BCG and Pr55 gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons
Data(s) |
2009
|
---|---|
Resumo |
Mycobacterium bovis BCG is considered an attractive live bacterial vaccine vector. In this study, we investigated the immune response of baboons to a primary vaccination with recombinant BCG (rBCG) constructs expressing the gag gene from a South African HIV-1 subtype C isolate, and a boost with HIV-1 subtype C Pr55 gag virus-like particles (Gag VLPs). Using an interferon enzyme-linked immunospot assay, we show that although these rBCG induced only a weak or an undetectable HIV-1 Gag-specific response on their own, they efficiently primed for a Gag VLP boost, which strengthened and broadened the immune responses. These responses were predominantly CD8+ T cell-mediated and recognised similar epitopes as those targeted by humans with early HIV-1 subtype C infection. In addition, a Gag-specific humoral response was elicited. These data support the development of HIV-1 vaccines based on rBCG and Pr55 gag VLPs. © 2009 Elsevier Ltd. All rights reserved. |
Identificador | |
Relação |
DOI:10.1016/j.vaccine.2009.05.064 Chege, G. K., Thomas, R., Shephard, E. G., Meyers, A., Bourn, W., Williamson, C., Maclean, J., Gray, C. M., Rybicki, E. P., & Williamson, A. L. (2009) A prime-boost immunisation regimen using recombinant BCG and Pr55 gag virus-like particle vaccines based on HIV type 1 subtype C successfully elicits Gag-specific responses in baboons. Vaccine, 27(35), pp. 4857-4866. |
Palavras-Chave | #Baboons #HIV vaccines #Recombinant BCG #Virus-like particles |
Tipo |
Journal Article |